{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0007155",
      "entity_text" : "adhesion",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04048",
      "entity_text" : "senicapoc",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Preclinical studies and clinical trials targeting three different sickle cell pathways will be reviewed, including inhibition of adhesion by poloxamer 188, inhibition of Gardos channel induced erythrocyte dehydration by senicapoc (ICA-17043), and treatment of acute pain episodes with inhaled nitric oxide.",
  "reading_complete" : "2020-08-04T18:07:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T17:59:44Z",
  "trigger" : "inhibition",
  "evidence" : [ "inhibition of adhesion by poloxamer 188, inhibition of Gardos channel-induced erythrocyte dehydration by senicapoc" ],
  "pmc_id" : "3621302",
  "score" : 0
}